Certara Inc

$17.56 0.00% ($0.00)
  • 1D
  • 1W
  • 1M
  • 1Y
  • 5Y
  • YTD

Get ready to invest

Subscribe

About Certara Inc

Certara, Inc. is a provider of biosimulation software and technology-enabled services. The Company is focused on producing medicines for patients using biosimulation software and technology to transform traditional drug discovery and development. Biosimulation is a technology used to conduct virtual trials using virtual patients to better understand how drugs behave in different individuals. The Company builds its biosimulation technology on the first principles of biology, chemistry, and pharmacology with mathematical algorithms that model how medicines and diseases behave in the body. Its software and technology-enabled services include Mechanistic Biosimulation Platform (Simcyp); Empirical Pharmacokinetic and Pharmacodynamic Biosimulation (Phoenix); Scientific Informatics Platform (D360); Clinical Outcomes Databases for Biosimulation (CODEx); Authoring and Management of Regulatory Submissions Platform (GlobalSubmit), And Market Access Communication Platform (BaseCase).

Stock Analysis

last close $17.56
1-mo return -22.6%
3-mo return 0.7%
avg daily vol. 757.68T
52-week high 45.48
52-week low 16.18
market cap. $3.8B
forward pe 32.3
annual div. -
roe -1.3%
ltg forecast 40.4%
dividend yield -
annual rev. $301M
inst own. -
baraka

Subscribe now for daily local and international financial news

Subscribe